118 related articles for article (PubMed ID: 1486065)
1. Iron(III) chelating resins II. 3-Hydroxy-4(1H)-pyridinones-sepharose gels.
Feng M; van der Does L; Bantjes A
J Biomater Sci Polym Ed; 1992; 4(2):145-54. PubMed ID: 1486065
[TBL] [Abstract][Full Text] [Related]
2. Iron(III) chelating resins--I. Preparation and properties of Sepharose-desferrioxamine gels.
Feng M; van der Does L; Bantjes A
J Biomater Sci Polym Ed; 1992; 4(2):99-105. PubMed ID: 1486067
[TBL] [Abstract][Full Text] [Related]
3. Preparation of apolactoferrin with a very low iron saturation.
Feng M; van der Does L; Bantjes A
J Dairy Sci; 1995 Nov; 78(11):2352-7. PubMed ID: 8747325
[TBL] [Abstract][Full Text] [Related]
4. Iron removal from milk and other nutrient media with a chelating resin.
Feng M; van der Does L; Bantjes A; de Groote JM
J Dairy Sci; 1995 Jan; 78(1):55-61. PubMed ID: 7738259
[TBL] [Abstract][Full Text] [Related]
5. New hydroxypyridinone-functionalized sepharoses as sorbing agents for hard metal ions.
Grazina R; Santos MA
J Hazard Mater; 2011 Feb; 186(2-3):1902-8. PubMed ID: 21239106
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
Rai BL; Dekhordi LS; Khodr H; Jin Y; Liu Z; Hider RC
J Med Chem; 1998 Aug; 41(18):3347-59. PubMed ID: 9719587
[TBL] [Abstract][Full Text] [Related]
7. Iron (III)-chelating resins. 3. Synthesis, iron (III)-chelating properties, and in vitro antibacterial activity of compounds containing 3-hydroxy-2-methyl-4(1H)-pyridinone ligands.
Feng MH; van der Does L; Bantjes A
J Med Chem; 1993 Sep; 36(19):2822-7. PubMed ID: 8410996
[TBL] [Abstract][Full Text] [Related]
8. Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics.
Liu G; Men P; Kenner GH; Miller SC; Bruenger FW
Nucleosides Nucleotides Nucleic Acids; 2004; 23(3):599-611. PubMed ID: 15113026
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
Dobbin PS; Hider RC; Hall AD; Taylor PD; Sarpong P; Porter JB; Xiao G; van der Helm D
J Med Chem; 1993 Aug; 36(17):2448-58. PubMed ID: 8355246
[TBL] [Abstract][Full Text] [Related]
10. Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.
Rangel M; Leite A; João Amorim M; Garribba E; Micera G; Lodyga-Chruscinska E
Inorg Chem; 2006 Oct; 45(20):8086-97. PubMed ID: 16999406
[TBL] [Abstract][Full Text] [Related]
11. Combined chelation of bi-functional bis-hydroxypiridinone and mono-hydroxypiridinone: synthesis, solution and in vivo evaluation.
Gama S; Gil M; Gano L; Farkas E; Amélia Santos M
J Inorg Biochem; 2009 Feb; 103(2):288-98. PubMed ID: 19091421
[TBL] [Abstract][Full Text] [Related]
12. Structures of 3-hydroxy-1-(2-methoxyethyl)-2-methyl-4-pyridinone, its hydrochloride and 1-ethyl-3-hydroxy-2-methyl-4-pyridinone hydrochloride hydrate.
Xiao G; van der Helm D; Goerlitz FH; Hider RC; Dobbin PS
Acta Crystallogr C; 1993 Sep; 49 ( Pt 9)():1646-9. PubMed ID: 8217022
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate-appended 3-hydroxy-4-pyridinone complexes of the [M(CO)3]+ core (M = Re, 99mTc, 186Re).
Ferreira CL; Bayly SR; Green DE; Storr T; Barta CA; Steele J; Adam MJ; Orvig C
Bioconjug Chem; 2006; 17(5):1321-9. PubMed ID: 16984143
[TBL] [Abstract][Full Text] [Related]
14. New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation.
Grazina R; Gano L; Sebestík J; Amelia Santos M
J Inorg Biochem; 2009 Feb; 103(2):262-73. PubMed ID: 19062099
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and iron(III)-chelating properties of novel 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers.
Zhou T; Kong XL; Liu ZD; Liu DY; Hider RC
Biomacromolecules; 2008 May; 9(5):1372-80. PubMed ID: 18373358
[TBL] [Abstract][Full Text] [Related]
16. Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties, and biological activity.
Streater M; Taylor PD; Hider RC; Porter J
J Med Chem; 1990 Jun; 33(6):1749-55. PubMed ID: 2342069
[TBL] [Abstract][Full Text] [Related]
17. A new approach for potential combined chelation therapy using mono- and bis-hydroxypyridinones.
Santos MA; Gama S; Gil M; Gano L
Hemoglobin; 2008; 32(1-2):147-56. PubMed ID: 18274992
[TBL] [Abstract][Full Text] [Related]
18. Iron(III)-chelating resins. IX. Antibacterial activity of a water-insoluble iron(III)-chelating resin.
Feng M; van der Does L; Bantjes A
J Med Chem; 1994 Apr; 37(7):924-7. PubMed ID: 8151619
[TBL] [Abstract][Full Text] [Related]
19. Molecular structure and biological and pharmacological properties of 3-hydroxy-2-methyl-1-(beta-D-ribofuranosyl or pyranosyl)-4-pyridinone: potential iron overload drugs for oral administration.
Liu G; Bruenger FW; Miller SC; Arif AM
Bioorg Med Chem Lett; 1998 Nov; 8(21):3077-80. PubMed ID: 9873679
[TBL] [Abstract][Full Text] [Related]
20. The influence of linkages between 1-hydroxy-2(1H)-pyridinone coordinating groups and a tris(2-aminoethyl)amine core in a novel series of synthetic hexadentate iron(III) chelators on antimicrobial activity.
Workman DG; Hunter M; Wang S; Brandel J; Hubscher V; Dover LG; Tétard D
Bioorg Chem; 2020 Jan; 95():103465. PubMed ID: 31855824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
